Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Biological DMARDs----2件: 86, 107
2Classic DMARDs treatment group----1件: 46
3Co-medication: Synthetic DMARDs----1件: 46
4Combination of DMARDs----1件: 107
5Conventional DMARDs----1件: 46
6Disease-modifying antirheumatic drugs (DMARDs)----1件: 46
7DMARDS----2件: 46, 271
8DMARDs (disease-modifying antirheumatic drugs)----1件: 46
9DMARDs (methotrexate1件: Methotrexate2件: D00142 ,
2件: DHFR,
5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
10DMARDs or Biologics----1件: 46
11Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc1件: Etanercept1件: D00742 2件: LTA,
67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
12HUC-MSC + DMARDs----1件: 46
13Non-Biologic DMARDs----3件: 46, 86, 107
14Non-biological DMARDs----1件: 46
15Nonbiologic DMARDs of investigator's choice----1件: 46
16Other DMARDs----1件: 46
17Other: Group 2 (DMARDS treated group)----1件: 46
18Permitted DMARDs----1件: 46
19Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)----1件: 46
20Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)----1件: 46
21UC-MSC+DMARDS----1件: 46